TSMC Projects $1.5T Semiconductor Market by 2030 as AI Demand Surges
Technology Sarah Chen

TSMC Projects $1.5T Semiconductor Market by 2030 as AI Demand Surges

TSMC now expects the global semiconductor market to exceed $1.5 trillion by 2030, fueled by AI. The company also outlined aggressive capacity expansion and advanced packaging milestones.

TSM INTC SSNLF NVDA AAPL MSFT META GOOGL AMZN
Dow Edges Higher as Treasury Yields Retreat, Bond Warning Persists
Markets Daniel Marsh

Dow Edges Higher as Treasury Yields Retreat, Bond Warning Persists

The Dow Jones rose 0.22% on Monday as Treasury yields eased, but bond market warnings remain as oil prices stay elevated. Dominion Energy surged on a $66.8 billion NextEra deal.

DIA SPY QQQ D TLT USO NEE REGN NVDA WMT
Dow Inches Higher, Nasdaq Slips as Bond Yield Retreat Fails to Calm Markets
Markets Daniel Marsh

Dow Inches Higher, Nasdaq Slips as Bond Yield Retreat Fails to Calm Markets

Stocks were mixed Monday as the Dow edged up but the Nasdaq fell, with bond yields pulling back from recent highs. Dominion Energy jumped on a $66.8B acquisition by NextEra, while Regeneron slid on a trial miss.

DOW SPY QQQ TLT NVDA SOXX D DUK NEE AES CEG REGN WMT HD TGT TJX USO GLD
Intel Edges Higher as AI-Driven Demand Offsets Market Jitters
Technology Sarah Chen

Intel Edges Higher as AI-Driven Demand Offsets Market Jitters

Intel shares inched up Monday as analysts raised targets and the AI narrative gained traction. Data center revenue surged 22%, but server CPU market share slipped.

INTC AMD NVDA SOXX
BofA Turns Bearish on Salesforce, Flags AI Risk to Growth Model
Analysis Daniel Marsh

BofA Turns Bearish on Salesforce, Flags AI Risk to Growth Model

BofA Securities reinstated Salesforce with an Underperform rating and $160 target, citing AI risks to its growth model. Shares rose despite the bearish note.

CRM
VTI Attracts $852M Inflows Despite Weekly Decline
Markets Daniel Marsh

VTI Attracts $852M Inflows Despite Weekly Decline

VTI pulled in $852 million in net inflows over five days despite a weekly drop, driven by demand for AI-linked tech stocks and broad market exposure.

VTI NVDA AAPL MSFT QQQ
Sanctions Waiver Hints Send Oil Lower, Bonds Steady Amid Strait of Hormuz Crisis
Commodities Rebecca Torres

Sanctions Waiver Hints Send Oil Lower, Bonds Steady Amid Strait of Hormuz Crisis

Oil prices fell Monday after reports the U.S. may offer Iran a temporary sanctions waiver, easing earlier panic over the closed Strait of Hormuz. Brent crude dropped below $108, while the 10-year Treasury yield hit 4.631%.

SPY USO UNG GLD NVDA AMD INTC WMT
Alphabet Stock Gains Ahead of Google I/O; BofA Reaffirms Buy Rating
Technology Sarah Chen

Alphabet Stock Gains Ahead of Google I/O; BofA Reaffirms Buy Rating

Alphabet shares rose over 1% Monday, nearing $4.9 trillion market cap, as Bank of America reiterated Buy with $430 target ahead of Google I/O. Analysts highlight AI and cloud momentum but caution on elevated expectations.

GOOGL GOOG MSFT AMZN BKNG EXPE
Quince Therapeutics Faces Nasdaq Listing Uncertainty Amid Going Concern Warning
Markets Daniel Marsh

Quince Therapeutics Faces Nasdaq Listing Uncertainty Amid Going Concern Warning

Quince Therapeutics stock trades near $1.15 as the company faces Nasdaq compliance issues, a going concern warning, and a failed Phase 3 trial, with a shareholder vote on a reverse stock split scheduled for June 11.

QNCX
Berkshire Hathaway Takes Stake in Macy's; Stock Rises in Pre-Market
Markets Daniel Marsh

Berkshire Hathaway Takes Stake in Macy's; Stock Rises in Pre-Market

Berkshire Hathaway's new 3.04 million share stake in Macy's, valued at $55 million, lifted shares in pre-market. Q1 results are due June 3, with headwinds from tariffs and weak spending.

M BRK.B
ImmunityBio Secures Patents and BCG Supply Deal for Bladder Cancer Therapy
Technology Sarah Chen

ImmunityBio Secures Patents and BCG Supply Deal for Bladder Cancer Therapy

ImmunityBio announced five U.S. patents protecting its Anktiva-plus-BCG bladder cancer therapy through 2035, and an exclusive supply deal for the Tokyo-172 BCG strain.

IBIO
Markets Daniel Marsh

Virax Biolabs Surges on TV Segment and Ownership Filing

Virax Biolabs shares surged over 125% in pre-market trading Monday after a sponsored TV segment featuring its CEO and a new SEC filing revealed Armistice Capital holds a 4.99% stake.

VRAX